IL116726A - Enrofloxacin injection or infusion solutions - Google Patents

Enrofloxacin injection or infusion solutions

Info

Publication number
IL116726A
IL116726A IL11672696A IL11672696A IL116726A IL 116726 A IL116726 A IL 116726A IL 11672696 A IL11672696 A IL 11672696A IL 11672696 A IL11672696 A IL 11672696A IL 116726 A IL116726 A IL 116726A
Authority
IL
Israel
Prior art keywords
infusion solutions
enrofloxacin injection
enrofloxacin
injection
infusion
Prior art date
Application number
IL11672696A
Other languages
English (en)
Other versions
IL116726A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL116726A0 publication Critical patent/IL116726A0/xx
Publication of IL116726A publication Critical patent/IL116726A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11672696A 1995-01-13 1996-01-10 Enrofloxacin injection or infusion solutions IL116726A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19500784A DE19500784A1 (de) 1995-01-13 1995-01-13 Enrofloxacin-Injektions- oder Infusionslösungen

Publications (2)

Publication Number Publication Date
IL116726A0 IL116726A0 (en) 1996-05-14
IL116726A true IL116726A (en) 2000-07-16

Family

ID=7751383

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11672696A IL116726A (en) 1995-01-13 1996-01-10 Enrofloxacin injection or infusion solutions

Country Status (28)

Country Link
US (1) US5998418A (pt)
EP (1) EP0806955B1 (pt)
JP (1) JP3835815B2 (pt)
CN (1) CN1125635C (pt)
AR (1) AR002265A1 (pt)
AT (1) ATE261731T1 (pt)
AU (1) AU695171B2 (pt)
BR (1) BR9510444A (pt)
CA (1) CA2210076C (pt)
CZ (1) CZ293934B6 (pt)
DE (2) DE19500784A1 (pt)
DK (1) DK0806955T3 (pt)
ES (1) ES2215183T3 (pt)
FI (1) FI119970B (pt)
HU (1) HU226826B1 (pt)
IL (1) IL116726A (pt)
JO (1) JO1883B1 (pt)
MX (1) MX9705266A (pt)
NO (1) NO313537B1 (pt)
NZ (1) NZ298778A (pt)
PL (1) PL182095B1 (pt)
PT (1) PT806955E (pt)
RU (1) RU2147225C1 (pt)
SK (1) SK284348B6 (pt)
TW (1) TW416852B (pt)
UA (1) UA42819C2 (pt)
WO (1) WO1996021453A1 (pt)
ZA (1) ZA96244B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
JP5002462B2 (ja) * 2004-12-09 2012-08-15 バイエル・アニマル・ヘルス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 酸によるグルココルチコイドエステルの安定化
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CN100341510C (zh) * 2005-06-10 2007-10-10 冯莉萍 一种恩诺沙星微囊及制备方法
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
CN101230333B (zh) * 2007-01-26 2010-08-18 台湾尖端先进生技医药股份有限公司 恩罗氟沙星的单株抗体及其检测套组
US20100247687A1 (en) * 2009-03-30 2010-09-30 Mary Arnold-Ronish Formulation for tattoo removal and method of using same
CN101810569B (zh) * 2010-05-22 2011-09-21 鼎正动物药业（天津）有限公司 一种恩诺沙星注射液及其制备方法
CN103479569A (zh) * 2013-01-14 2014-01-01 四川喜亚动物药业有限公司 兽用环丙沙星注射液及其制备方法
RU2574007C2 (ru) * 2013-10-16 2016-01-27 Олег Иванович Киселев Инъекционный раствор для лечения вирусных заболеваний, выбранных из гриппа h1n1, h3n2, h5n1, клещевого энцефалита и лихорадки западного нила
US9993421B2 (en) * 2015-11-20 2018-06-12 Dynamo, Llc Method for treating deleterious effects arising from tattoos
CN107095848A (zh) * 2017-07-01 2017-08-29 山东中牧兽药有限公司 一种恩诺沙星注射液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
ES8304117A1 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
US5998418A (en) 1999-12-07
NO313537B1 (no) 2002-10-21
CZ293934B6 (cs) 2004-08-18
HUT77942A (hu) 1998-12-28
ZA96244B (en) 1996-07-31
BR9510444A (pt) 1998-05-19
DK0806955T3 (da) 2004-07-12
DE59510878D1 (de) 2004-04-22
CN1177300A (zh) 1998-03-25
PL182095B1 (pl) 2001-11-30
DE19500784A1 (de) 1996-07-18
JO1883B1 (en) 1996-07-25
SK94697A3 (en) 1997-11-05
CZ213097A3 (en) 1997-10-15
JP3835815B2 (ja) 2006-10-18
NZ298778A (en) 1999-05-28
CN1125635C (zh) 2003-10-29
CA2210076C (en) 2007-12-18
NO973223L (no) 1997-07-10
CA2210076A1 (en) 1996-07-18
SK284348B6 (sk) 2005-02-04
PT806955E (pt) 2004-06-30
FI972966A (fi) 1997-07-11
HU226826B1 (en) 2009-11-30
EP0806955B1 (de) 2004-03-17
RU2147225C1 (ru) 2000-04-10
EP0806955A1 (de) 1997-11-19
IL116726A0 (en) 1996-05-14
UA42819C2 (uk) 2001-11-15
MX9705266A (es) 1997-10-31
WO1996021453A1 (de) 1996-07-18
PL321259A1 (en) 1997-11-24
ES2215183T3 (es) 2004-10-01
NO973223D0 (no) 1997-07-10
AU695171B2 (en) 1998-08-06
AU4434996A (en) 1996-07-31
ATE261731T1 (de) 2004-04-15
FI119970B (fi) 2009-05-29
FI972966A0 (fi) 1997-07-11
TW416852B (en) 2001-01-01
JPH10511967A (ja) 1998-11-17
AR002265A1 (es) 1998-03-11

Similar Documents

Publication Publication Date Title
HUP0000893A3 (en) Hypodermic injection system
EP0858351A4 (en) ANTI-SHUTTERING NEEDLE
EP0841962A4 (en) CAMOUFLEED INJECTION NEEDLE
HUP9800523A3 (en) Insulin derivatives
GB2317104B (en) Infusion container
EP0971758A4 (en) SYSTEM FOR INTRUSIVE INFUSION
GB9520243D0 (en) Injector
AU4494196A (en) Needle-less injector
IL116726A (en) Enrofloxacin injection or infusion solutions
GB2289503B (en) Injection systems
GB2308302B (en) Syringe
GB9525369D0 (en) Injector
HUP9901087A3 (en) Injection needle
GB9513967D0 (en) Insulin
ZA963669B (en) Infusion device
GB2300121B (en) Complete infusion set
GB9524722D0 (en) Syringes
GB9502280D0 (en) Needle-less injector
GB9502299D0 (en) Needle-less injector
GB9709506D0 (en) Hypodermic injection system
TW363421U (en) Alarm device for intravenous injection
GB9507411D0 (en) Liquid injector
TW370880U (en) Intravenous injection alarm
GB9608782D0 (en) Needleless injector drug capsile
GB9408096D0 (en) Injector system

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees